Dextech Medical AB (XSAT: DEX)
Health Care · Biotechnology · SE
Skr—
— today · — 1Y
Dextech Medical AB (XSAT: DEX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $18.89M.
trading between 5.85 and 14.40.
Tweenvest scores Dextech Medical AB across four factors: quality 53/100, value 63/100. Its strongest factor is value.
DEX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $18.89M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.35
- Dividend yield
- —
- Beta (5Y)
- 1.31
- 52-week high
- Skr14.40
- 52-week low
- Skr5.85
- Avg volume (3M)
- —
- Shares outstanding
- 18.49M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Resverlogix Corp.TSX: RVX | $19.47M | CA$0.08 | -5.88% |
| Inhibitor Therapeutics, Inc.OTCPK: INTI | $19.10M | $0.11 | +12.14% |
| GenSight Biologics S.A.ENXTPA: SIGHT | $19.05M | €0.07 | -5.00% |
| HST Global, Inc.OTCPK: HSTC | $18.91M | $0.13 | -80.90% |
| General Biologicals CorporationTPEX: 4117 | $18.79M | NT$8.61 | -8.31% |
| Quoin Pharmaceuticals, Ltd.NasdaqCM: QNRX | $18.74M | $3.90 | -13.33% |
| Estrella Immunopharma, Inc.NasdaqCM: ESLA | $18.70M | $0.43 | +4.88% |
| Akari Therapeutics, PlcNasdaqCM: AKTX | $18.69M | $8.18 | -6.73% |
Figures last refreshed Oct 18, 2026.